Antiresorptive Consolidation After Osteoanabolic Therapy
This cohort study examines the clinical implementation of timely consolidation with antiresorptive therapy to preserve bone mineral density gains and reduce fracture risk.
Authors
- Rozalina Grubina McCoy (ORCID: https://orcid.org/0000-0002-2289-3183)
- Jeph Herrin (ORCID: https://orcid.org/0000-0002-3671-3622)
- Juan Pablo Brito (ORCID: https://orcid.org/0000-0003-1840-1745)
- Alexander Everhart (ORCID: https://orcid.org/0000-0001-5192-6557)
- Joseph Theressa Nehu Parimi
- Pinar Karaca Mandic
- Sanaa Badour
- Mark Takagi
Institutions
- University of Maryland, Baltimore (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Diabetes Australia (AU)
- Veterans Health Administration (US)
- Foundation for the National Institutes of Health (US)
- Yale University (US)
- Optum (United States) (US)
- Center for Advancing Health (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1001/jamainternmed.2025.7530
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00